Loading...

HSDT HELIUS MEDICAL TECHNOLOGIES INC Management Changes 8-K Filing

HLS

HSDT

HELIUS MEDICAL TECHNOLOGIES INC

(HSDT)

2025 8-K

Summary

Summary

Corporate Update

Stockholder Meeting Results

Correction Issued

Press Release Issued

Accountant Changes

Name Change Announcement

Executive Bonuses

Company Announcement

Funding Initiatives

Stock Offering Announcement

$500M Fundraising

Product Expansion

Equity Offerings

Equity Offerings

Equity Offerings

Rights Offerings

Reverse Stock Split

Equity Offerings

Annual Meeting Results

Nasdaq Compliance

Nasdaq Compliance Issue

Warrant Inducement

Medicare Rates Update

PoNS Sale Announcement

Strategic Alternatives

Financial Results

Compliance with Nasdaq List...

Annual Meeting Announcement

Earnings Reports

Public Offering

Financial Results Announcement

Bylaws Amendments

CMS Reimbursement for PoNS ...

Regulation FD Disclosure

Earnings Reports

Earnings Reports

Assignment of UPCs to PoNS ...

Reverse Stock Split

Financial Results Announcement

Sales Agreement with Roth C...

Annual Meeting Results

Results of Operations and F...

Delisting Notice

Financial Results Announcement

Financial Results and Corpo...

External Links:

On September 24, 2025, Helius Medical Technologies awarded $890,000 and $610,000 cash bonuses to CEO Dane C. Andreeff and CFO Jeffrey S. Mathiesen, respectively, while confirming no change in control occurred from previous offerings.

AI Assistant

HELIUS MEDICAL TECHNOLOGIES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.